1 / 43

Drugs used in GIT disorders

Mgr. Petra Hirsova Dept . o f Pharmacology 2011. Drugs used in GIT disorders. Overview. Pharmacotherapy of peptic ulcer Drugs that increase GIT motility Purgatives Antidiarrheal agents Spasmolytic agents. Peptic ulcer. Lesion of gastric or duodenal mucosa :

dayo
Download Presentation

Drugs used in GIT disorders

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Mgr. Petra Hirsova Dept. ofPharmacology 2011 Drugsused in GIT disorders

  2. Overview Pharmacotherapy ofpepticulcer Drugsthatincrease GIT motility Purgatives Antidiarrhealagents Spasmolyticagents

  3. Pepticulcer Lesion ofgastricorduodenalmucosa: Chronic and recurrent Lesiondeeperthanmuscularis mucosae(x erosion) In proximity of acidigastricjuice → autodigestionofmucosa Imbalancebetweenaggressiveandprotectivefactors Incidence ofpepticulcer: 5-10 % ofpopulation

  4. Pepticulcer - etiology Primary ulcer Helicobacter pylori being the main or the only factor Secondary ulcers: Stress-related(burns, trauma) Drug-related(NSAID, ASA) Endocrine(Zollinger-Ellison syndrome) Age-related(vascular and trophicfactors) Ulcerlocalization: Gastric x duodenal

  5. Peptic ulcer - symptoms Abdominalpain (in 90 % ofcases) Ulcerperforation and bleeding(melena, hematemesis) in 10 % of c. Gastriculcer Painaftermealorwithin 1 hour(up to ulcerlocalization) Frequentdyspepsia (lackofappetite, nausea, weightloss, belch) Duodenalulcer Painwhenfasted (>2 h aftermeal), during night Painrelievedwithmeal! Waterbrush, regurgitation)

  6. Regulationofgastric acid secretion - 1 • Nervous • ACH, M1/3rcp. • Endocrine • Gastrin • Paracrine • Histamine n.vagus

  7. Regulationofgastric acid secretion

  8. Aggressivea protectivefactors- 1 Aggressivefactors: Endogenous: Chloric acid (HCl) Activatedpepsin Duodenalsecretion– reflux (bileacids, pepticenzymes…) Exogenous: Helicobacterpyloriinfection Alcohol(especial. spirits) Smoking & nicotine Coffee & coffein Drugs (NSAID a glucocorticoids!!!) Stress!

  9. Aggressive a protectivefactors - 2 Protectivefactors: Mucus(rightcomposition and amount) Intactmicrocirculation in gastricmucosa Alkalicsecretionofbicarbonate (HCO3-) Normalsynthesis and secretionof prostaglandin E2 and I2 ↑ Mucus and bicarbonatesecretion ↑ Mucosaperfusion (dilationeffect) ↓ HClsecretion

  10. Therapeuticaims No pain and dyspepsia To healtheulcer To preventulcerrecurrence Possiblepharmacologicalintervention ↑ gastricpH ↓ HClsecretion EradicationH. pylori Gastrointestinalmucosaprotection Cytoprotectiveagents– enhancementofendogenousfactors

  11. Antacids- 1 NeutralizegastricHCl (chemicalreaction) Immediate and shorteffect(usedbeforeeverymeal) Most ofthemover-the-counter Local x systemeffect NaHCO3= Sodiumbicarbonate, CaCO3are absorbedfrom GIT → alkalosis Someformprotectivelayer on thestomachsurface Al(OH)3= Aluminium hydroxyde, Mg2(SiO3)3 = Magnesium trisilicate

  12. Antacids- 2 Otherdrugs: MgO/Mg(OH)2= Magnesium hydroxide Adverseeffects: Constipation (CaCO3, Al3+) x diarrhea (Mg2+) Drug-druginteractions: May decreaseabsorption and BAV ofco-administereddrugs Indication: Symptomatictreatmentofdyspepsiarelated to excessivegastric acid secretion, heartburn, waterbrash Gastroesophageal reflux disease (GERD)

  13. Drugsused to inhibitgastric acid secretionSelectiveparasympatholytics Lowclinicalsignificance – not in use (lowerantisecretionefficacy /adverseeffects) Pirenzepine (Gastrozepin) M1-selective parasympatholytic(competitiveantagonist) Adverseeffects– typicalanticholinergiceff. Contraindication– e.g. glaucoma, urine retention… Replaced by PPi

  14. Drugsused to inhibitgastric acid secretionHistamine H2rcpantagonists– 1 Ranitidine, famotidine, nizatidine,cimetidine (withdrawn) Selectivecompetitiveantagonistsof H2 histaminereceptors Inhibitbasal, night and inducedsecretion (by histamine) Administered per os (possiblyparenterally), goodabsorptionfrom GIT Adverseeffects: Rare (ranitidine, famotidine)- headache, confusion (espec. theold), GIT disturbaces; very rarelybradycardia and negative inotropicefefect Cimetidine– inhibitor of CYP450! – frequentdrug-druginteractions AE: as above + gynecomastia, decrease in sexualfunction

  15. Drugsused to inhibitgastric acid secretionHistamine H2rcpantagonists – 2 H2 rcpantagonistscure most ulcers (80-90 %) within 6 weeksx recurrenceis very frequent!!! Indication: Lightdyspepsia, waterbrash… Pepticulcerprophylaxis Pepticulcertreatment – not a choiceoftreatment (x iPP) !!! Contraindication: pregnancy, lactation, malignantulcer

  16. Proton pump inhibitors - 1 Omeprazole, pantoprazole, lansoprazole, esomeprazole Irreversibleproton pump inhibition (H+/K+-ATPasa) Final step in HClproduction→ inhibitionofsecretionis independent ofinducing stimulus! Long-term effect – synthesisofnewH+pump isneeded(functionrecoveredafter ~4 days) Drugs of choice for peptic ulcers!!! When combined with H.pylori eradication , therecurrence of peptic ulcer is 0 – 10 %

  17. Proton pump inhibitors - 2 Unstable in acids – decomposed in stomach→ enterosolvent capsules Parenterally in urgent situations (ulcerperforation) Prodrug Absorbedfromtheintestine → systemiccirculation → weak base = accumulation in acidic pH ofparietalcells(= plasma Cssisminimal) → bioactivation and proton acceptance (“ion-trap“) → covalent bond to proton pump Utmosteffect– aftermaximalstimulationofparietalcells→ used in themorning (fastedstomach)

  18. Proton pump inhibitors - 3 • Indication: • Pepticulcer • Zollinger-Ellison syndrome (adenoma→ hypergastrinemia)‏ • Gastroesophageal reflux disease • H. pylorieradication • Prophylaxis in high-risk patientstreatedwithNSAIDs • Pregnancy & lactation: yesafterbalancingrisks and benefits • (excretedintothemilk – 6% of plasma level) • Adverseeffects: • Very welltolerated (headache, dyspepsia; very rarelyalterationofbloodformation)‏ Combinationwith histamine H2 rcpantagonistsis not rationalbecause Ppi actdirectlyagainstthe cause

  19. Drugsprotectingthemucosa - 1 Produceprotectivebarrier on gastric and duodenalmucosa →protectulcerlesionsagainsttheaggressivegastricjuice Sucralfate – aluminium hydroxid + sulfatedsucrose Indication: Stress-relatedulcers, prophylaxis in high-risk patients and in patiens in remission Not absorbedfrom GIT AcidicpHneededfortheeffect – don’t use togetherwithantacids! Formprotectivebarrier, binds pepsin and bileacids StimulatessecretionofPGE2and I2 AE:mostlyconstipation Drug-drug I:decreasesabsorptionofotherdrugs

  20. Drugsprotectingthemucosa - 2 Alginates Polysaccharidefromseaalgae Becomesviscous (protectsesophagusmucosa) Forms gel in thestomach (floating – blockesophageal reflux) Alsocombinedwithantacids Bi3+compounds: Bismuthchelate Antibacterialaction(in combinationforH.pylorieradication) Coatingoftheulcer base Stimulatessecretionof PGE2 and I2 AE:headache, dyspepsia, constipation, vomiting Not recommended in pregnancy

  21. Cytoprotectivedrugs Misoprostol, enprostil Stablesynthetic prostaglandin derivatives (PGE2 a PGI2) PGE2cannotbeused – highlyunstable Indication: Prophylaxisfor NSAID adverseeffects (long-term therapy, highdoses, high-risk patients) Adverseeffects diarrhea, colic, nausea, flatulence Contraindication Pregnancy(risk ofabortion)‏ Expensive – not in use (not registered in Czech)‏

  22. Helicobacterpylorieradication Eradicationiscrucialforrecurrencefrequency Successfuleradication: 0-9% CombinationofPPi(omeprazoleorpantoprazole) and two ATB (amoxicillin, clarithromycin, metronidazole) Most commoncombinations(2 x daily, 7 days) Omeprazole+amoxicillin+clarithromycin(up to 96%) Omeprazole+metronidazole+clarithromycin(up to 95%) Omeprazole+amoxicillin+metronidazole(up to 79%) Possible to use bismuthchelates, histamine H2rcpantagonists(↓ effect)

  23. Drugsincreasing GIT motility - 1 ↑ sphincter tonus ofesophagus(blocksesophageal reflux) ↑ gastricemptying(improvesymptomsofgastroparesis, dyspepsia, etc.) ↑ gut motility Antiemeticaction Mechanismofaction: D2-rcp antagonism entericneurons- disinhibition→ ↑ acetylcholine secretion area postrema pituitary – adverseeffect– hyperprolactinemia within CNS – extrapyramidaladverseeffects Inhibitionof acetylcholine esterase (AChE) Stimulationof 5-HT receptorů (5-HT4, 5-HT1)

  24. Drugsincreasing GIT motility - 2 Domperidone Competitive D2-antagonist Doesn’t cross HEB– effect on centers outside ofHEB Rare AE: GIT disorders, hyperprolactinemia Don’t combinewithstrong CYP3A4inhibitors (ketokonazole, erythromycin– QT interval prolongation ) Not recommendedduringpregnancy and lactation Metoclopramide D2-antagonist, agonist on 5-HT4rcpand sensitizationofM-rcpto ACh Crosses HEB→ possibleextrapyramidaladverseeffects inCNS Rare AE: acutedyskinesia (children), parkinsonismsa latedyskinesia(olderpatients), malignanthypertermia, hyperprolactinemia Strongantiemeticaction(more thandomperidone) Don’t use in1sttrimester of pregnancy andduring lactation

  25. Drugsincreasing GIT motility - 3 Itopride D2-antagonist andinhibitor of AChE Contraindicated during pregnancy and lactation AE: rarely diarrhea, ↑ salivation and epigasticpain, headache, prolactinemia Cisapride– withdrawn Agonist on 5-HT4 rcp Metabolized by CYP450 – drug-druginteractions Serious AE: QT interval prolongation Risk offatalcardiacarrhythmias – „torsadesde pointes“

  26. Purgatives - 1 Hastenthe transit of food throughtheintestine Mainindication: Symptomatictreatmentofacuteconstipation (individualsuitabilitymustbeassessed) Prior to GIT surgeryorexamination Constipation Lowfrequenceofbowelmovements(hugeinterindividual variability) Change in consistency, painfuldefecation Effectof diet and lifestyle Lackoffiber, pectins, liquids, lackofexercise/moving

  27. Purgatives - 2 Risk factors: Pregnancy Higherage(lackofmoving, worse diet) Immobility Constipation as a symptom ofotherdisease: ! Malignanciesobstructingthe GIT ! Constipationas a consequentof pharmacotherapy: Opioids (no tolerance develops) Anticholinergicagents, antidepressants, histamine rcpantagonists Ifpossible, changethe pharmacotherapy

  28. Purgatives - 3 Bulklaxativesorfecalsofteners Saline and osmoticlaxatives Stimulant laxatives Non-pharmacologicalmeasurements are part ofthetherapy Not for long-term use – often OTC drugsoverused Contraindications: Bowelobstruction Pregnancy(exceptforbulklax.) and lactation(stimulant laxativesexcretedintothemilk)

  29. Bulklaxatives Semisynthetic:methylcelulose, carboxymethylcelulose Natural:agar, psyllium Indigestible polysaccharides attract water→ swell and from bulky gel mass→ gut distension and stimulation ofmotility Effect within 1-3 days! Sufficient liquid intake is critical (guidance to patients) – complications when dehydrated! Other beneficial effects: binding of bile acids, carcinogen protection… AE: minimal – well tolerated (depletion of minerals)… OK for long-term use; safe in pregnancy

  30. Osmotic and salinelaxatives - 1 Non-absorbable, osmoticallyactive Stay in the gut lumen and attractwater Increasemass → gut distension and peristalsispromotion Actwithin 1-3 hours Adverseeffects: Spasms, colic, dehydration, electrolyteloss Often prior gut surgery and examination Salinelaxatives: Magnesium sulfate, sodiumsulfate Specialmineralwaters (Šaratica, Zaječická...)

  31. Osmotic and salinelaxatives - 2 Osmotic: Lactulose Cleaved by intestinalbacteria to lactate and acetate→ decreases pH→ improvedintestinal flora Decreasedproductionof NH3 by intestinalbacteria(usefulfor liver encephalopathy) Lactitol, sorbitol Glycerol In suppositories, relativelygentle and safelaxative to renew a lostdefecation reflex Makrogol 4000 (polyethylenglycol4000) Similar to glycerol, prior to endoscopy...

  32. Stimulant laxatives- 1 Absorbedfromthe GIT, metabolized – effectafter6 h Irritate gut mucosa Decreaseabsorptionofwater and electrolytes Increasesecretion and gut motility (direct stimulationofmyentericnerves?) Not for long-term use!!! Canlead to irreversibledamageor gut amyotonia ↑ absorptionoftoxins Contraindication: Pregnancy(risk ofabortion), lactation(excretedintothemilk) Adverseeffects: spasms, colics,dehydration, electrolyteloss

  33. Stimulant laxatives - 2 Natural drugs: Foliumsennae, Rhizomarhei, Aloe, Cortexfrangulae glycosidsabsorbedfromtheproximal GIT → activeformssecretedintolarge gut Dye urine (darkred-brown) Excretedintothemilk(diarrhea in babies) Syntheticdrugs: Bisacodyl, sodium picosulfate AE: allergy, fotosensitivity

  34. Fecalsofteners Nonabsorbable→ soften Facilitatemovements Liquidparaffin Mineraloil = mixtureofnonabsorbablehydrocarbons Adverseeffects: Longertreatmentcanlead to vitamini A, D, E, K deficiency(due to theirdecreasedabsorption) Smallpercentagecanbeabsorbed (deposition in the liver) In highdoses – colicpain

  35. Antidiarrhealagents Diarrhea Higherfrequencyofbowelmovements(waterystools) Abdominaldiscomfort, evenspasms and pain Risk ofdehydration and electrolyteimbalance Varied etiology: Infection(salmonella, shigella, campylobacter…) Yeasts Toxins Drugs(Mg2+, damage to intestinal flora by broad-spectrum ATB, cytostatics, anticholinergics, verapamil, digoxine)

  36. Intestinaladsorbents Charcoal(Carboadsorbens, medicinalis), diosmectite (kaolin) Act on basicsofphysics– unselective Adsorptionoftoxins, bacteria on itssurface Indication:diet errror, yeastovergrowth, intoxication Rareadverseeffects: Low toxicity, for a limited timecanbeadministered in relativelyhighdoses (at least grams) Drug-druginteractions: Unselectiveaction– adsorbdrugson thesurface

  37. Intestinaldesinfectionagents Broad-spectrumaction(bacteria, yeasts, some protozoa) Don’t interferewithnormalintestianl flora No resistancedevelop! Cloroxin- OTC Not for more than 10 days (otherwise risk of GIT toxicity) Nifuroxazide - Rx Nonabsorbablefromthe GIT! Indication: Diarrheawithanticipated etiology ofinfection Traveler’s diarrhea

  38. Antidiarrhealagents – Opioids - 1 Significantly decreased GIT motilityandincreased water absorption Effect on μ- a δ-receptors in enteric nervous system Indication: Acuteexhaustingdiarrhea(lossofelektrolytes) Non-infectiousdiarrhea Tinctura opii Strongeffect Morfine, codeine and papaverine (spasmolytics) Not forkids! (respirationdepression)

  39. Antidiarrhealagents – Opioids – 2 In today’s use: Low risk of abuse and dependencydevelopment Diphenoxylate In normaldoses has no opioideffects in CNS, onlyreallyhighdoses (orwhencombinedwithalcohol) Combinationwith atropine („Reasec“) Loperamide Does not crossHEB No risk ofdependency and abuse Rareadverseeffects – safe in general Oftenused (OTC – „Imodium“)

  40. GIT spasmolytics Smoothmusclespasmrelief Combinedwithanalgetics(pethidine, codeine, metamizole, tramadol) Indication: Irritablebowel syndrome, flatulance, otherspasms in GIT Colics– intestinal, bililary, renal Contraindications: paralyticileus Neurotropicspasmolytics(anticholinergics, parasympatholytics) Myotropicspasmolytics(papaverine and similar) Oftentheircombination

  41. Neurotropicspasmolytics Parasympatholytics (M-rcpantagonists) Atropine, tolterodine and trospium Paradoxically cause spasmofsphincters – SphincterofOddie! AE: typicalanticholinergic– xerostomia, mydriasis, cycloplegia, glaucom!, urine retention, psychotropiceffect… Anticholinergics(both M and N rcpantagonists) Otilonium, fenpiverinium Effect on sphincters Very strongeffect LowerabsorptionfromtheGIT → lower risk of AE in CNS Bettertolerated

  42. Myotropicspasmolytics - 1 Act directly on smooth muscles (w/o sign. neuronal regulation) Act partly on vascular smooth muscle → cardiovascular adverse effects Various modes of action: Ca2+channel blocade, K+channel activation Activation of adenylcyclase (production of cAMP, cGMP) → inactivation of proteinkinase, stimulation of NO production Often combined with analgetics Natural opioid alkaloids: Papaverine Quinoline derivativefrom opium (X opioidanalgetics) Spasmolysis of smooth muscles - both vascular and other i.v: strong vasodilation, ↓BP, bradycardia, AV blocs CI: glaucoma, intracranial hypertension, respiratory center depression

  43. Myotropicspasmolytics - 2 Synthetic derivatives: Drotaverine, mebeverine, alverine, pitofenone Stronger myotropic effect than papaverine Fewer adverse effects Indication: irritable bowel sy, diverticulosis, spasms (gut, biliary, ureter), intestinal discomfort i.v. – arrhythmogenicandhypotension effects Spasmoanalgetics Short-term and intensive treatment Analgetics withspasmolytic effect (pethidine,tramadol) Combination of spasmolytics with analgetics(, metamizole, acetaminophen, codeine) Metamizole + fenpiverine + pitofenone Indication: Spastic pain, spastic dysmenorrhea Spasmoanalgesia before and after examination, gynecologic surgeries

More Related